MSB 0.76% $1.31 mesoblast limited

Mesoblast Phase 2 Trial Results Show Early and Durable Effects of Single Mesenchymal Precursor Cell, page-174

  1. 4,002 Posts.
    lightbulb Created with Sketch. 315
    You could be right!

    We aren't the only company exploring stem cells on the same medical needs.

    I also wouldn't show details to companies who will be abolished by our technology if successful!

    I'm sure details can be given to prospective partners that isn't disclosed to market!

    Maybe I just come from a protective viewpoint too much!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.31
Change
-0.010(0.76%)
Mkt cap ! $1.495B
Open High Low Value Volume
$1.31 $1.33 $1.28 $1.819M 1.396M

Buyers (Bids)

No. Vol. Price($)
2 29972 $1.31
 

Sellers (Offers)

Price($) Vol. No.
$1.31 2008 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.